• Company
• Somavert for terminal hypertrophy can be prescribed at Big 5
• by Eo, Yun-Ho Apr 14, 2022 05:56am

• Policy
• Omicron recombinant XL mutation found in Korea
• by Lee, Jeong-Hwan Apr 14, 2022 05:56am

• Policy
• P3T for Roche’s Giredestrant was approved in Korea
• by Lee, Hye-Kyung Apr 14, 2022 05:56am

• Policy
• Why Galvusmet is priced same as salt-modified and generics
• by Lee, Tak-Sun Apr 13, 2022 06:03am

• Company
• “NOAC Eliquis is safe for use in high-risk groups”
• by Apr 13, 2022 06:02am

• Policy
• Korea loses $9 billion a year in exports
• by Lee, Jeong-Hwan Apr 13, 2022 06:02am

• Company
• Propecia is sold in a new package
• by Apr 13, 2022 06:02am

• Policy
• Galvusmet latecomers face a price war since launch
• by Lee, Tak-Sun Apr 12, 2022 06:05am

• Company
• KRPIA BOD meets Oh Chang-hyun, the new head
• by Eo, Yun-Ho Apr 12, 2022 06:05am

• Company
• No. of employees decline sharply due to restructuring/reorgs
• by Apr 12, 2022 06:04am